Christopher Salerno to Stroke
This is a "connection" page, showing publications Christopher Salerno has written about Stroke.
Connection Strength
1.813
-
HVAD to HeartMate 3 left ventricular assist device exchange: Best practices recommendations. Eur J Cardiothorac Surg. 2022 06 15; 62(1).
Score: 0.448
-
HVAD to HeartMate 3 Left Ventricular Assist Device Exchange: Best Practices Recommendations. Ann Thorac Surg. 2022 06; 113(6):1770-1777.
Score: 0.441
-
Early elevations in pump power with the HeartMate II left ventricular assist device do not predict late adverse events. J Heart Lung Transplant. 2014 Aug; 33(8):809-15.
Score: 0.252
-
Concurrent valvular procedures during left ventricular assist device implantation and outcomes: A comprehensive analysis of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 trial portfolio. J Thorac Cardiovasc Surg. 2023 12; 166(6):1684-1694.e18.
Score: 0.111
-
HVAD to HeartMate 3 left ventricular assist device exchange: Best practices recommendations. J Thorac Cardiovasc Surg. 2022 06; 163(6):2120-2127.e5.
Score: 0.110
-
Primary results of long-term outcomes in the MOMENTUM 3 pivotal trial and continued access protocol study phase: a study of 2200 HeartMate 3 left ventricular assist device implants. Eur J Heart Fail. 2021 08; 23(8):1392-1400.
Score: 0.104
-
Comprehensive Analysis of Stroke in the Long-Term Cohort of the MOMENTUM 3 Study. Circulation. 2019 01 08; 139(2):155-168.
Score: 0.088
-
The HVAD Left Ventricular Assist Device: Risk Factors for Neurological Events and Risk Mitigation Strategies. JACC Heart Fail. 2015 Oct; 3(10):818-28.
Score: 0.070
-
Is pre-transplant vascular disease a risk factor for mortality and morbidity after heart transplantation? Eur J Cardiothorac Surg. 2007 Mar; 31(3):457-61.
Score: 0.039
-
Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized Trial. JAMA. 2022 09 27; 328(12):1233-1242.
Score: 0.029
-
A Fully Magnetically Levitated Left Ventricular Assist Device - Final Report. N Engl J Med. 2019 04 25; 380(17):1618-1627.
Score: 0.022
-
Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study. Circulation. 2018 10 30; 138(18):1923-1934.
Score: 0.022
-
Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure. N Engl J Med. 2018 Apr 12; 378(15):1386-1395.
Score: 0.021
-
Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure. Circulation. 2017 May 23; 135(21):2003-2012.
Score: 0.020
-
A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure. N Engl J Med. 2017 02 02; 376(5):440-450.
Score: 0.019
-
Factors Related to Pump Thrombosis With the Heartmate II Left Ventricular Assist Device. J Card Surg. 2015 Oct; 30(10):775-80.
Score: 0.017